Ebola virus (EBOV) causes a lethal hemorrhagic fever for which there is no approved effective treatment or prevention strategy. EBOV VP35 is a virulence factor that blocks innate antiviral host responses, including the induction of and response to alpha/ beta interferon. VP35 is also an RNA silencing suppressor (RSS). By inhibiting microRNA-directed silencing, mammalian virus RSSs have the capacity to alter the cellular environment to benefit replication. A reporter gene containing specific microRNA target sequences was used to demonstrate that prior expression of wild-type VP35 was able to block establishment of microRNA silencing in mammalian cells. In addition, wild-type VP35 C-terminal domain (CTD) protein fusions were shown to bind small interfering RNA (siRNA). Analysis of mutant proteins demonstrated that reporter activity in RSS assays did not correlate with their ability to antagonize double-stranded RNA (dsRNA)-activated protein kinase R (PKR) or bind siRNA. The results suggest that enhanced reporter activity in the presence of VP35 is a composite of nonspecific translational enhancement and silencing suppression. Moreover, most of the specific RSS activity in mammalian cells is RNA binding independent, consistent with VP35's proposed role in sequestering one or more silencing complex proteins. To examine RSS activity in a system without interferon, VP35 was tested in well-characterized plant silencing suppression assays. VP35 was shown to possess potent plant RSS activity, and the activities of mutant proteins correlated strongly, but not exclusively, with RNA binding ability. The results suggest the importance of VP35-protein interactions in blocking silencing in a system (mammalian) that cannot amplify dsRNA.
bola virus (EBOV), a member of the Filoviridae, is a class A priority pathogen. The most pathogenic strains (e.g., Zaire) cause severe hemorrhagic fever in humans, with a fatality rate of up to 80 to 90% (20) . Although there have been several promising vaccine approaches and postexposure antisense therapeutics in nonhuman primates, no licensed vaccines or specific therapeutics currently exist for the prevention or treatment of human EBOV infections (14, 27, 41, 47, 50) . Moreover, EBOV blocks the induction of interferon (IFN) and does not respond to exogenous IFN in vivo or in vitro (1, 17, 18, 22, 24) . Most of this antagonism is mediated by EBOV VP35 (1-3), a multifunctional 340-aminoacid (aa) protein that is also an essential viral RNA polymerase cofactor and a structural component of the virion (21, 36, 37) . In addition to its ability to bind double-stranded RNA (dsRNA), EBOV VP35 blocks activation of IRF-3 and/or IRF-7. It also directly or indirectly interacts with a number of cellular proteins, including the kinases IB kinase (IKK) and TBK-1, required to phosphorylate and translocate these IRFs to the nucleus to induce transcription of type 1 IFNs (2, 7, 8, 38) . VP35 also facilitates the addition of SUMO to IRF-7, most likely by interacting with several proteins required for the process (8) . The C-terminal domain (CTD) of VP35 (aa 215 to 340) is responsible for all, or nearly all, of these activities and has been referred to as the IFN-inhibitory domain (VP35 IID) (1, 19) . VP35 has also been shown to inhibit and reverse the activation of the dsRNA-activated protein kinase R (PKR), another important effector of the IFN pathway. Though the mechanism is unknown, VP35's effect on PKR is apparently RNA independent and prevents the phosphorylation and inactivation of the important translation factor eIF-2␣ (12, 45) .
In addition to its effects on the IFN pathway, VP35 has been demonstrated to be a potent RNA silencing suppressor (RSS) (15) . RNA silencing pathways are highly conserved among plants, animals, fungi, and fission yeast (44) and, therefore, likely represent some of the most primordial defense mechanisms. Indeed, it is well established that RNA silencing is an innate antiviral defense in plants, and virtually all plant viruses encode one or more RSS proteins that act as pathogenicity determinants (reviewed in references 10, 31, and 40). Many of these RSSs have been shown to block small interfering RNAs (siRNAs) and/or pathways required for their generation (4, 28) . Moreover, many plant virus RSS proteins also interfere with microRNA-directed silencing (25) . The role of RSSs in the pathogenicity of mammalian viruses has been the subject of great debate. However, because the microRNA pathway is a major posttranscriptional regulatory mechanism in mammals, the ability of a virus to suppress microRNA-directed silencing globally or specifically could alter the cellular environment to enhance virus replication and/or spread. Thus, the ability of VP35 to interfere with microRNA-directed silencing could enhance the ability of EBOV to replicate. The loss of most of the RSS activity of VP35 with mutation of arginine 312 to alanine (R312A) suggested to earlier investigators that silencing suppression activity required the ability of VP35 to bind dsRNA (15) , since the R312A mutant protein failed to bind dsRNA in vitro (7) . However, structural studies have revealed that R312 of VP35 is involved not only in interactions with the backbone phosphates of dsRNA, but also in protein-protein interactions at the interface of monomers in the asymmetric dimer of the VP35 CTD that forms in cocrystals with dsRNA (26, 30) . Thus, it remains unclear whether RNA silencing inhibition by VP35 depends on dsRNA binding.
To better understand the means by which VP35 suppresses RNA silencing and to investigate its ability to interfere with microRNA silencing, we employed assays that reflect the microRNA-directed silencing pathway that is used by mammals, as well as the siRNA-directed pathway involved in natural antiviral defenses in plants. Plant silencing suppression assays have the additional advantage of avoiding any direct or indirect links with IFN pathways. We also report on the ability of the VP35 CTD to bind directly to the small dsRNAs that are mediators of siRNAand microRNA-directed responses. The results suggest that microRNA-directed silencing suppression in mammalian cells involves mostly RNA-independent mechanisms. In contrast, in plants that rely heavily on dsRNA amplification, RNA-dependent mechanisms predominate.
MATERIALS AND METHODS
Plasmids. The pCMV-Luc-miR30 reporter and pSuper-miR30 plasmids were obtained from Bryan Cullen and have been described in detail elsewhere (54, 56, 57) . pCMV-Luc-miR30 allows high-level constitutive expression of an mRNA containing the firefly luciferase (Fluc) open reading frame (ORF) with 8 tandem repeats of a microRNA 30 (miR30) target sequence in the 3= untranslated region (UTR). The pSuper-miR21 plasmid was derived by cloning human miR21 sequences into the pSuper backbone. pSuper-miRs are expressed from the human H1 RNA polymerase III promoter sequences. pRLCMV was obtained from Promega (Madison, WI) and expresses Renilla luciferase (Rluc) from the human cytomegalovirus (HCMV) RNA polymerase II promoter. The plasmid pEGFP-C2 was obtained from Clontech (Mountain View, CA) for HCMV promoter-driven expression of enhanced green fluorescent protein (EGFP) in mammalian cells. Plasmid p19-FLAG expresses the plant virussilencing suppressor under HCMV promoter control (39) and was the kind gift of Kathy Boris-Lawrie (Ohio State University). The EBOV VP35 gene (Zaire) was the kind gift of Chris Basler (Mt. Sinai Medical Center). The plasmids pcDNA4/TO, pCEP4-tetR, and pcDNA4/TO-LacZ have been described previously (52, 53) and were kind gifts of Feng Yao (Harvard Medical School). To facilitate detection, the VP35 ORF was placed downstream of an N-terminal c-myc epitope tag composed of the DNA sequence 5=-ATGGAACAAAAACTCATCTCAGAAGAGGATCTG-3= and cloned into the pcDNA 3.1 and pcDNA4/TO mammalian expression vectors. The pcDNA4/TO vector contains the HCMV immediate-early promoter and 2 tetracycline (TET) operator sequences to permit doxycycline (DOX)-inducible expression in cells that express the TET repressor (52) but constitutive expression in cells without the TET repressor. To obtain maltose binding protein (MBP) fusions with the CTD of VP35, the plasmid pMAL-5cE (New England Biolabs, Beverly, MA) was cleaved with KpnI, blunted, and ligated to the sequences encoding the myc tag linked to aa 215 to 340 of the wild-type VP35 gene (obtained by linked PCR). The K309A, R312A, and G333S mutations in the VP35 gene were prepared by nested PCR and transferred to the indicated expression plasmids by switching subdomains containing these mutations with the analogous wild-type VP35 sequences. Plasmids containing the p19 plant virussilencing suppressor and ␤-glucuronidase (GUS) genes downstream of the constitutive Cauliflower mosaic virus 35S promoter were positive and negative controls, respectively, for plant silencing suppression assays and have been described elsewhere (49) . The myc-VP35 genes (wild type and mutants) were also cloned downstream of the 35S promoter in the same plasmid background for expression in plants. DNA sequencing was performed to confirm the open reading frames within all plasmids constructed. Additional cloning details are available upon request.
Transient transfections. Baby hamster kidney (BHK), human 293T, or 293T derivative cells were seeded into 35-or 60-mm culture dishes in antibiotic-free Dulbecco's modified minimum essential medium (DMEM) containing 10% fetal bovine serum and incubated overnight at 34°C in a humidified 5% CO 2 atmosphere to achieve 50 to 80% confluence. Approximately 1 h prior to transfection, the culture medium was changed to serum-and antibiotic-free DMEM containing 0.1 mM nonessential amino acids. DNA mixtures containing constant amounts of DNA (700 ng/35-mm dish or 2 g/60-mm dish) and lipofectamine 2000 (Invitrogen; 4.25 l/dish) were added to cells in Opti-MEM low-serum medium as described previously (51) . The DNA mixtures were prepared with the amounts of individual plasmids indicated for each experiment, with the remaining DNA comprised of empty-vector sequences (pUC19 or pCDNA3.1). Four hours after transfection, the medium was replaced with DMEM containing 10% fetal bovine serum, and the cells were incubated as before and were harvested as indicated for each experiment. For some experiments, as indicated, a second transfection was performed 24 h after the first.
Preparation and cultivation of stable cell lines. Human 293T cells were transfected with pCEP4-tetR plasmid (700 ng) and incubated for 2 to 4 weeks in medium containing hygromycin (50 g/ml) to obtain TET repressor (tetR)-expressing cell lines. Culture medium was replenished every 3 to 4 days, and clones resistant to hygromycin were picked and expanded. The clones were functionally screened for the presence of tetR protein by the ability to regulate expression of a test plasmid (pcDNA4/ TO-LacZ) containing the Escherichia coli lacZ gene downstream of the TET operator. When transfected with up to 20 ng of pcDNA4/TO-LacZ and in the absence of induction, the tetR-expressing cell line selected (6c3) displayed no detectable ␤-galactosidase (␤-Gal) protein by either X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) staining or immunoblotting with ␤-Gal antibody. However, high levels of ␤-Gal expression were observed when similarly transfected cells were incubated in the presence of DOX (1 g/ml) for 24 h. Cell line 6c3 was transfected with the zeocin-selectable vector pcDNA4/TO containing either the VP35 (wild type or mutant) or lacZ gene, and clones resistant to zeocin (250 g/ml) were isolated. Stably transfected cell lines were maintained continuously in medium containing hygromycin (50 g/ml) and zeocin (250 g/ml) and were screened by immunoblotting for relevant protein expression in the absence or presence of DOX (1 g/ml) for 24 h. The C-terminal halves of the VP35 genes from mutant and wild-type cell clones were PCR amplified from purified total cellular DNA, and the sequences were confirmed.
Antibodies and immunoblotting. Cells from parallel cultures used for luciferase assays were harvested by scraping the cell monolayers into the medium, followed by low-speed centrifugation. The cell pellets were washed twice in ice-cold phosphate-buffered saline (PBS), flash frozen in liquid nitrogen, and stored at Ϫ80°C. The cells were suspended in buffer containing 0.1 M Tris-Cl, pH 8.0, 150 mM NaCl, 10% glycerol, 0.5% Nonidet P-40, 0.5% Na deoxycholate and lysed by ultrasonic disruption at 0°C. The suspensions were clarified by low-speed centrifugation, and the protein content in the supernatant was determined using a Coomassie blue dye-based assay (Bio-Rad) with bovine serum albumin as the standard. Equivalent amounts of protein were separated by SDS-PAGE, and the proteins were transferred to nitrocellulose membranes. The membranes were blocked in PBS containing 10% nonfat dry milk, washed extensively with PBS containing 0.1% Tween 20, and then incubated with a 1:5,000 dilution of mouse monoclonal antibody 46-0603 to c-myc (Invitrogen), a 1:666 dilution of rabbit polyclonal antibody to ␤-Gal (5=-3= Inc., West Chester, PA), or a 1:500 dilution of rabbit polyclonal antibody to GFP (Santa Cruz), as indicated. Following extensive washing, the blots were incubated with a 1:10,000 dilution of horseradish peroxidaseconjugated goat anti-mouse or anti-rabbit IgG (Thermo) and developed using the Super Signal West Pico Chemiluminescent kit according to the instructions of the manufacturer. The blots were exposed to X-ray film for 1 to 10 s and developed.
Luciferase assays. The dual-luciferase reporter assay kit from Promega (Madison, WI) was employed, using an active lysis procedure according to the instructions of the manufacturer. Cells in 35-or 60-mm dishes were seeded and/or pretreated as indicated for each experiment. Twenty-four hours later, the cells were transfected with pCMV-LucmiR30 (30 ng/35-mm dish or 90 ng/60-mm dish), pCMV-Rluc (2 or 6 ng for 35-or 60-mm dishes, respectively), mixtures of pSuper-miR30 and/or pSuper-miR21 as indicated in each experiment, and vector plasmid filler as described above. In some experiments, test expression plasmids were transfected 24 h after cell seeding, and a second transfection with the luciferase and miR expression plasmids was performed 24 h thereafter. At 48 h after transfection with luciferase plasmids, cells were harvested by scraping and washed twice in ice-cold PBS. Cells from each culture dish were suspended in 1 ml lysis buffer supplied by the manufacturer, flash frozen in liquid nitrogen, and stored at Ϫ80°C. The cells were lysed using 3 freeze-thaw cycles, and the lysates were clarified by centrifugation at 13,500 ϫ g for 5 min. The supernatants were assayed immediately according to the manufacturer's instructions or stored at Ϫ20°C prior to assay. Luminescence was read using a microplate luminometer (Packard, Meriden, CT). Three readings were taken for each sample, adjusted for background luminescence, and averaged. The average luminescence values from three to six independent replicate cultures were also averaged to obtain each data point reported. A two-way Student's t test was performed to determine whether observed differences in data were statistically significant (P Ͻ 0.05).
Affinity purification of MBPs and RNA binding assays. E. coli containing the pMal-5cE plasmid for expression of MBP or plasmid to express an MBP fusion protein with the C-terminal domain (aa 215 to 340) of wild-type or mutated VP35 were grown to mid-log phase (A 600 ϭ 0.5) at 37°C. Protein expression was subsequently induced by the addition of IPTG (isopropyl-␤-D-thiogalactopyranoside) (0.3 mM). Cells from 1 liter of culture were harvested 2 h after induction and suspended in 25 ml of column buffer (20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM EDTA, 1 mM sodium azide, and 10 mM 2-mercaptoethanol). The cells were lysed at 0°C by intermittent ultrasonic disruption in 10-s increments for approximately 2 min of sonication time using a Branson model 350 sonicator microprobe at setting 5. After sonication, the cellular membranes were removed by centrifugation at 20,000 ϫ g for 20 min at 4°C. The supernatants (extracts) were collected and used immediately or were stored at Ϫ80°C prior to affinity purification of MBPs. Two-milliliter columns of amylose resin (New England BioLabs, Beverly, MA) were prepared and equilibrated with column buffer according to the instructions of the manufacturer. Bacterial extracts (1 ml or equivalent to extract from 40-ml culture) were diluted 1:6 in column buffer and applied to amylose columns. Unbound proteins were removed by washing with 10 column volumes.
32 P-labeled dsRNA or oligo(dT) 20 , prepared as described below, was added to columns containing the bound MBP or MBP fusion protein and incubated at room temperature for 10 min. Unbound nucleic acid was removed by washing with 10 volumes of column buffer. MBP and MBP fusion proteins, together with bound nucleic acid, were eluted by the addition of 10 mM maltose in column buffer. A total of 30 fractions (0.4 ml each) were collected, and 5 l from each fraction was spotted onto a Whatman 3MM filter, dried, and counted by liquid scintillation spectrometry. Nucleic acids were 5= end labeled with [␥-32 P]ATP and T4 bacteriophage polynucleotide kinase and purified by standard procedures. RNA binding assays used 50 g poly(I) · poly(C) for long dsRNA (specific activity, 1.1 ϫ 10 6 dpm/g), 24 ng oligo(dT) 20 (4.6 ϫ 10 8 dpm/g), or 146 ng siRNA (2.6 ϫ 10 8 dpm/g) per column. The lengths of the poly(I) · poly(C) duplexes (Sigma, St. Louis, MO) were variable. Oligo(dT) 20 and siRNA were obtained from IDT (Coralville, IA) and Ambion (Austin, TX), respectively. The siRNA contained two annealed 21-nucloetide (nt) RNAs with 19 perfect base pairs and 2-nt 3= single-strand overhangs at each end.
Plant silencing suppression assays. Two-and three-component silencing suppressor assays have been described previously (23, 49) . Briefly, wild-type Nicotiana benthamiana plants were used in the threecomponent assay, while the two-component assay utilized transgenic N. benthamiana plants expressing GFP from a Cauliflower mosaic virus 35S promoter (line 16c; provided by David Baulcombe, Cambridge University) (42) . Agrobacterium harboring plasmids for expression of the GFP silencing target, a long hairpin of GFP (dsGFP) to induce silencing, and/or a protein of interest or control were mixed at equal volumes (A 600 ϭ 1) and coinfiltrated into the underside of 3 leaves per plant using a 1-ml syringe. In all cases, expression was driven by the 35S promoter. GFP fluorescence was analyzed 3, 5, and 7 days postinfiltration with a longwave UV lamp (Blak-Ray Model B 100YP; UV Products). Photographs of individual leaves were obtained using a Nikon D40 camera with UV and yellow filters at a uniform exposure.
RNA extraction and Northern blot analysis. Northern blot procedures have been described previously (49) . Leaf discs containing the infiltrated zones were obtained from 3 plants (weighing approximately 0.15 g total), and RNA was extracted using 1 ml TRIzol Reagent (Invitrogen). RNA loaded onto gels for Northern blots contained 5 g for each sample, with the exception of p19 samples, for which 1 g of RNA was loaded. Following RNA transfer, the membranes were probed with a GFP antisense riboprobe synthesized with [␣-
32 P]UTP using the Maxiscript T7 kit (Ambion) according to the instructions of the manufacturer.
RESULTS
EBOV VP35 can suppress microRNA-directed silencing in mammalian cells. Haasnoot and coworkers (15) were the first to describe EBOV VP35 as an RSS. In their studies, short hairpins were targeted to the open reading frame to silence firefly luciferase reporter activity, and EBOV VP35 was shown to suppress this silencing. Inasmuch as gene silencing in mammalian cells occurs by the targeting of cellular microRNA to predominantly untranslated sequences, and since microRNA silencing could alter the cellular environment to enhance virus replication, we wished to examine the ability and specificity of EBOV VP35 to interfere with microRNA-directed silencing in mammalian cells. A modification of the reporter assay developed by Zeng et al. was employed (57) . The reporter construct consisted of the Fluc gene linked to 8 tandem repeats of the miR30 target sequence within the 3= UTR sequences. When cotransfected with plasmid constructs encoding the target Fluc and the irrelevant Rluc used as a transfection control, the miR30-encoding plasmid severely diminished relative Fluc (Fluc/Rluc) activity compared to the activity observed when no miR-expressing plasmid was added or when cells were cotransfected with an irrelevant miR21 in 2 different cell types (BHK and 293T) (Fig. 1A and B, respectively) .
Because our goal was to measure the ability of a viral protein to suppress silencing activity, it was important to determine the dose-response of the silencing activity of the miR30 expression construct. In preliminary experiments, we observed nearly complete silencing of Fluc activity when as little as 0.1 ng of miR30-encoding plasmid was used in some experiments, but the absolute responses were highly variable from experiment to experiment. We observed more consistent dose-responses when cells were transfected with a constant amount of microRNA-expressing plasmid in which the ratio of specific (miR30-expressing) to nonspecific (miR21-expressing) plasmid was varied. Examples of dose-response curves in BHK and 293T cells are shown in Fig. 1C and D, respectively. Regardless of the total amount (10 or 30 ng) of microRNA-expressing plasmid or the type of cell line used, we observed a negative logarithmic relationship between the relative dose of miR30-expressing plasmid and Fluc activity. In contrast, the level of activity of the irrelevant target gene product, Rluc, displayed no pattern of significant inhibition by miR30 (Fig. 1C  and D) .
EBOV VP35 prevents the establishment of miR-directed RNA silencing in mammalian cells. We first used cotransfection experiments to determine the ability of EBOV VP35 to suppress miR30-directed silencing of Fluc activity. For BHK cells, a mixture containing 0.15 ng miR30 and 9.85 ng miR21 was selected. This mixture incompletely silenced Fluc activity but left silencing of Fluc in a responsive range. The silencing mixture was cotransfected with expression plasmid encoding either EBOV VP35, an irrelevant protein (EGFP), or the plant virus RSS p19 linked to a FLAG epitope. Luciferase activity was compared to that in nonsilenced cells transfected with 10 ng miR21-expressing plasmid (see Fig. S1 posted at http://go.osu.edu/JVI5741-11Supplementary). Coexpression of EGFP and the silencing miR mixture resulted in an ϳ2.5-fold reduction in Fluc activity compared to the nonsilenced control. However, coexpression of EBOV VP35 and the silencing mixture restored Fluc activity. We also observed partial but significant restoration of Fluc activity by the p19 plant virus RSS. Because all plasmids were expressed at the same time, these results could not differentiate between the ability of VP35 to prevent the establishment of or to reverse miR-directed silencing.
A silencing mixture of 4 ng miR30 and 26 ng miR21 for 35-mm plates (or 12 ng miR30 and 78 ng miR21 for 60-mm plates) was selected as the most responsive ratio for silencing suppression experiments in 293T cells or their derivatives (see Fig. 1D ). Moreover, due to the high transfection efficiency of 293T cells, it was possible to perform sequential transfections to determine whether prior expression of VP35 or other proteins could prevent silencing by miR30. Cells were transfected with test expression plasmid 24 h prior to the addition of the reporter and miR expression plasmids for these experiments (Fig. 1E) . The miR30-miR21 mixture reduced Fluc expression with prior expression of EGFP compared to that observed when only miR21 was expressed. However, not only did prior expression of VP35 protein prevent the silencing of 293T cells, but VP35 expression led to even greater activity than was observed in nonsilenced cells. In contrast, we observed partial recovery of Fluc expression when cells were preincubated with the p19 plant virus RSS, though Fluc expression remained significantly below that observed in nonsilenced controls. Although this low level of silencing suppression by p19 reached significance in this experiment with 6 replicates, in others using only 3 replicates, we could discern no significant difference between Fluc activity with prior expression of p19 and that with the EGFP control (not shown). Analysis of test protein expression in silenced samples confirmed that all proteins were well expressed (Fig. 1F) . Thus, the low-level silencing suppression by p19 observed in either 293T or BHK cells ( Fig. 1E ; see Fig. S1 posted at http://go.osu.edu/ JVI5741-11Supplementary) is dwarfed by the high RSS activity of VP35 and VP35's ability to prevent the establishment of miRdirected silencing.
Ability of mutant EBOV VP35 to prevent miR-directed silencing in 293T cells. Because of the potent ability of miR30 to silence Fluc expression, it was important to ensure that all cells into which miR30 plasmid was introduced also expressed the test protein in order to accurately determine the abilities of mutated versions of VP35 to suppress miR-directed silencing. Thus, we established cell lines (derived from 293T cells) that would inducibly express wild-type VP35 or a mutated form thereof. The E. coli lacZ or EBOV VP35 gene was placed under the control of the TET operator and stably introduced into 293T cells that constitutively express the TET repressor, as described in Materials and Methods. Expression of TET operator-controlled genes is tightly regulated in these cell lines, since little or no protein was detected in the absence of the inducer, DOX. However, following 24 h in the presence of DOX (1 g/ml), substantial expression of the controlled genes was observed (Fig. 2B and C) . Visualization of X-Gal staining in lacZ-expressing cell lines demonstrated that gene expression was induced in Ͼ95% of the cells under these conditions (results not shown). The Fluc target reporter plasmid was introduced into the lacZ cell line, together with either 30 ng of miR21-expressing plasmid (not silenced) or a mixture of 4 ng miR30-and 26 ng miR21-expressing plasmid (silenced). The miR30-miR21 mixture was capable of silencing Fluc expression more than 2-fold, regardless of whether lacZ expression was induced by the addition of DOX (Fig.  2A) . These results indicate the specificity of silencing by miR30 and the absence of interference by inducible protein expression in the establishment of silencing by miR30. The abilities of wild-type and mutant VP35 genes to suppress the establishment of silencing by miR30 were tested in the relevant uninduced cell lines or those in which gene expression was induced with DOX for 24 h prior to transfection. We observed enhanced Fluc activity in the absence of induction for some of the cell lines (K309A and R312A), suggesting the presence of small but functional amounts of VP35 protein despite its lack of detection by immunoblotting (Fig. 2C) . The different absolute levels of Fluc activity without DOX induction therefore likely reflect different basal levels of expression of the proteins. Nevertheless, we observed significantly increased Fluc activity in cells induced to express either the wild-type (3.8-fold) or K309A or R312A mutant (2.2-and 1.7-fold, respectively) VP35 proteins compared to that expressed without induction ( Fig. 2A) . Moreover, the induced expression of wild-type VP35 or either of the VP35 mutants (K309A and R312A) significantly increased Fluc activity compared to that present in the induced lacZ control cells, demonstrating that much, though not all, of the RSS activity in VP35 (wild-type or mutant)-expressing cell lines was dependent upon induced protein expression. Notably, the R312A and K309A mutations, reported to completely abolish the dsRNA binding ability of VP35 (7, 12) , possessed significant RSS activity compared to the lacZ control. However, the RSS activity of the R312A mutant was significantly less than that observed following the induction of the wild-type or K309A mutant gene. Surprisingly, the Fluc activity in K309A-induced cells was as high as or higher than that observed in cells induced to express the wild-type VP35 ( Fig. 2A ). These differences were not due to differences in the levels of induced wild-type or mutant VP35 protein expression, since we observed comparable levels of protein expression in the silenced samples upon DOX induction (Fig. 2C) . Taken together, these results indicate that at least some of the RSS activity of VP35 in mammalian cells is RNA binding independent. However, because the RSS activities of the R312A and K309A mutants differed and previous experiments did not investigate the abilities of these mutants to bind to small RNA species, it was important to clarify the abilities of mutant proteins to bind to small RNAs structurally similar to those that mediate microRNA-directed silencing.
Ability of EBOV VP35 to bind siRNA. Although VP35 has been shown to bind to blunt-ended 5=-phosphorylated and nonphosphorylated RNA (7, 19, 26, 30) , its ability to bind to mediators of silencing suppression (with 3= OH overhangs) has not been determined. siRNAs are capable of knocking down gene expression in both plant and mammalian cells (reviewed in references 34, 43, and 48) and, like microRNAs, are incorporated into RNAinduced silencing complexes (RISCs) to mediate posttranscriptional silencing of mRNA. Both siRNAs and microRNAs contain a 19-nt duplex or partially duplex region with 3= overhangs of 2 nt on each end. Since the VP35 CTD has been shown to be involved in the dsRNA binding activities of the protein (7, 19, 30) , we expressed wild-type and mutant forms of this domain (amino acids 215 to 340) as an MBP fusion protein in bacteria. The functionality of purified MBP-VP35 CTD preparations (with a myc tag N terminal to the CTD) was first confirmed. Affinity columns containing either MBP or the MBP-VP35 CTD linked to amylose were prepared as described in Materials and Methods. Different forms of radioactively labeled nucleic acid were incubated with the bound proteins. MBP-containing proteins, together with nucleic acid bound to them, were then eluted by the addition of maltose.
In control experiments, we demonstrated that this procedure eluted MBP or MBP-VP35 with a purity of Ͼ95% (see Fig. S2 posted at http://go.osu.edu/JVI5741-11Supplementary). As shown in Fig. 3A and D, neither MBP nor the MBP-VP35 CTD protein was capable of binding a single-stranded DNA, oligo(dT) 20 . In contrast, MBP-VP35 CTD specifically bound poly(I) · poly(C) (Fig. 3E) , whereas MBP failed to bind this long (up to 2-kb) dsRNA (Fig. 3B) . MBP-VP35 CTD, but not MBP alone (Fig. 3F and C, respectively) , was also capable of binding siRNA. These results demonstrate that MBP-VP35 CTD binds both siRNA and larger dsRNA with high specificity under these conditions. We also tested the abilities of various VP35 mutations within this context to bind siRNA. As expected, we observed no significant binding of the siRNA to the MBP-K309A CTD or the MBP-R312A CTD or to a double mutant containing the R312A and K309A mutations (Fig. 3G to I ). These results confirm that wild-type VP35, or at least its CTD, is capable of stably binding siRNA with 2-nt 3= overhangs and that point mutations at R312 and/or K309 eliminate this binding. Together with the observation that both of these mutant proteins can enhance Fluc expression following miR-directed silencing in mammalian cells, though to different extents, these results also suggest that most of this ability is independent of RNA binding activity.
EBOV VP35 functions as a silencing suppressor in plants. EBOV VP35 has been shown to be a potent IFN antagonist, capable of blocking not only the induction of IFN-␤, but also downstream effectors of IFN, such as PKR (1) . Indeed, translational inhibition caused by the ability of activated PKR to phosphorylate the essential translation factor eIF-2␣ is also antagonized by VP35 (12, 45) . Inasmuch as miR-directed silencing in mammalian cells can lead to translational inhibition (35, 57) , assessment of the RSS activity of VP35 in mammalian cells using a reporter is complicated by the presence of the IFN pathway. In order to evaluate the inherent RSS activity of VP35 (wild type and mutants) independent of any effects it has on the IFN pathway, we used two wellestablished plant silencing suppressor assays (23), since plants neither encode IFNs nor respond to them. In the three-component system, potent silencing was established by introduction (via Agrobacterium infiltration of N. benthamiana leaves) of plasmids expressing the GFP gene and a long hairpin of GFP (dsGFP), and silencing suppression was determined by the simultaneous addition of a test gene. Expression of the GFP gene is silenced when the dsGFP is converted to short siRNAs, which then associate with RNA-silencing complex proteins (16, 23, 55) . The siRNAs may also be amplified by a plant-encoded RNA-dependent RNA polymerase that strengthens and facilitates the spread of the silencing response. In the two-component system, a GFP-transgenic line of N. benthamiana (line 16c) was used, and a GFP expression clone (which induces silencing of GFP mRNA originating from the transgene and the expression plasmid) was introduced at the same time as a test gene for silencing suppression. When plant leaves are examined under UV light, they appear red due to the inherent fluorescence of chlorophyll, and expression of GFP in the areas of infiltration is evident by the bright green color. In both systems, silencing developed over a period of several days, as indicated by the near absence of green color when the leaves were coinfiltrated with the negative-control test plasmid encoding GUS, which failed to suppress silencing ( Fig. 4A and B) . In contrast, GFP expression persisted even after 7 days when leaves were coinfiltrated with the potent plant virus RSS p19. The wild-type VP35 gene, expressed using the same strong 35S promoter, also suppressed silencing. As an additional control, we tested a G333S VP35 mutant, which was derived by the same PCR-directed mutagenesis and domain switching used to derive all of the mutant expression clones required for these experiments; however, the G333 residue lies outside the central patch of basic residues associated with RNA binding (30) . As expected, G333S displayed RSS activity similar to that displayed by wild-type VP35 (Fig. 4A and B) . Compared to the negative GUS control, low levels of GFP expression were still observed within the areas of infiltration in the presence of K309A of wild-type EBOV VP35 (MBP-VP35CTD) (D to F) or mutants containing K309A (G), R312A (H), or both (K/R) (I) mutations were expressed in E. coli. Clarified extracts of cells were bound to a 2-ml amylose column, and unbound proteins were removed by extensive washing as described in Materials and Methods. Radioactive nucleic acid, as indicated, was added to the column, followed by washes, and radioactivity bound to MBP or MBP fusion protein was eluted by the addition of 10 mM maltose in binding buffer. and R312A mutant VP35 genes, particularly in the twocomponent system (Fig. 4B) . However, both of these mutations clearly compromised the RSS activity of VP35. The double mutant reduced the RSS activity even further in the two-component system, though low residual GFP expression remained observable even after 7 days (Fig. 4B) .
The visual data in these assays were generally confirmed by Northern blots to determine changes in the steady-state levels of of Agrobacterium containing plasmids encoding GFP as a silencing target, a long dsGFP hairpin as the silencing inducer, and a test protein for silencing suppression as indicated. Expression of target, hairpin, and test genes were all under the control of the Cauliflower mosaic virus 35S constitutive promoter. On days 3, 5, and 7 postinfiltration, leaves were examined under UV light, and all leaves harvested on a given day were photographed at the same exposure level. Under UV light, the chlorophyll appears red, whereas GFP expression is green. The negative-control test protein for silencing suppression was GUS, and the positive-control silencing suppressor was p19 encoded by Cymbidium ringspot virus. Both WT and mutant forms of VP35 were individually tested. The results shown are representative leaves from at least 3 independent experiments in which 3 leaves of 10 plants were inoculated for each condition. (B) In this two-component assay, a GFP-transgenic line (line 16c) of N. benthamiana primed for silencing of GFP was used. Leaves were infiltrated with agrobacteria containing a plasmid that expresses GFP to induce silencing and a test plasmid for silencing suppression. Only leaves harvested on day 7 are shown. (C and D) Northern blots of RNA extracted from infiltrated leaf material from a three-component (C) or two-component (D) assay system. RNA was denatured and separated by electrophoresis through 1.2% agarose gels containing 1.3% formaldehyde. The RNA was transferred to a membrane and probed with [
32 P]GFP single-stranded RNA (ssRNA) antisense probe as indicated in Materials and Methods. For all samples except those containing the p19 plasmid, equivalent amounts of total RNA were loaded, as exhibited by ethidium bromide staining of 28S rRNA shown in the lower blots. Due to the high level of silencing suppression by p19 (and the corresponding high level of expression of GFP mRNA), the gels were loaded with 20% of the amount of RNA in other samples to prevent overexposure of the blots.
GFP mRNA within the areas of infiltration. In plants, siRNA generated in response to silencing results in specific cleavage of the target mRNA, leading to reduced steady-state levels. We isolated RNA from infiltrated spots 7 days after inoculation, separated the RNA by denaturing agarose gel electrophoresis, and probed transferred RNA with a GFP riboprobe. Northern blots of the RNA from infiltrated tissues from the three-and two-component assays are shown in Fig. 4C and D, respectively. The RNA load is indicated by the ethidium bromide staining of 28S rRNA in the gel prior to transfer. Because of p19's potent RSS activity (46), 5-fold less RNA was loaded for p19-containing samples to prevent overexposure of the blots. As expected, an extremely low steady-state level of GFP mRNA (barely detectable in the three-component system) was present in plants that received the negative control (GUS) plasmid compared to the levels in plants that received the positive-control p19 RSS or wild-type VP35 (Fig. 4C and D) . Of the VP35 mutants tested, only G333S possessed steady-state levels of GFP mRNA that were significantly greater than those of negative-control samples, confirming that in the presence of wildtype or G333S VP35, GFP mRNA degradation associated with silencing was inhibited. These results are consistent with the visual inspection of GFP expression in the plants (Fig. 4A and B) and demonstrate the ability of EBOV VP35 to act as an RSS in plants independent of the known effects of the protein on IFN response. Moreover, the results show that mutation of the R312 and/or K309 residue, which largely destroys the ability of VP35 to bind to siRNA, also eliminates most of the plant RSS activity. Thus, expression of EBOV VP35 in plants can either prevent the establishment of silencing and/or rapidly reverse it, and this response is highly dependent on the ability of the protein to bind siRNA or other intermediate RNA species in the silencing pathway.
DISCUSSION
Suppression of miR-directed silencing by EBOV VP35 in mammalian cells. In this report, we analyzed in greater detail the silencing suppressor activity of wild-type and mutant EBOV VP35 first reported by Haasnoot and colleagues (15) . Our results demonstrate that wild-type VP35 can specifically suppress microRNAdirected silencing in mammalian cells in which the target sequence is located in the 3= UTR of the reporter gene, the site where most microRNA targets are found. Our results also demonstrate that some mammalian cell lines differ in their relative susceptibilities to miR-directed silencing. In our hands, BHK cells are exquisitely sensitive to silencing, with Ͻ1 ng miR30-expressing plasmid resulting in a 5-fold reduction in target protein expression (Fig.  1C) . Although miR-directed silencing of human 293T cells also occurs, similar reductions in reporter silencing required transfection with much larger amounts of miR30-expressing plasmid (compare Fig. 1A and B) . By mixing the miR30-and miR21-expressing silencing plasmids, specificity of silencing response and better reproducibility were ensured (Fig. 1C and D) . Moreover, dose-response curves suggested ranges of silencing plasmids capable of distinguishing relative RSS abilities of test proteins. By using a small dose of miR30 relative to miR21 plasmid, VP35 consistently suppressed the silencing of target gene expression in both 293T and BHK cells ( Fig. 1E ; see Fig. S1 posted at http:// go.osu.edu/JVI5741-11Supplementary). The potent plant RSS p19, known to bind siRNA (6, 46) , possessed low, but significant, RSS activity in BHK and 293T cells, though only partial recovery from silencing occurred in both cell types. The p19 protein was shown previously to possess some RSS activity in miR-directed silencing assays in yet another cell type, HeLa cells (39) . Despite some quantitative differences in the amounts of silencing suppression observed in BHK and 293T cells, our results demonstrate conclusively that VP35 can prevent the establishment of miRdirected silencing.
To determine the relative differences in the activities of wildtype versus mutant VP35 genes, it was important to control for cell-line-or species-specific differences, as well as to ensure that essentially all of the cells receiving silencing plasmids also expressed the test RSS. This was achieved by deriving stable inducible cell lines from a single clone of 293T cells that constitutively expresses the TET repressor. These stable cell clones displayed little if any protein expression (detectable by immunoblotting) in the absence of DOX induction (Fig. 2B and C) . Introduction of the miR30/miR21-expressing plasmid mixture established effective silencing regardless of the addition of DOX, as shown in the lacZexpressing clones (Fig. 2A) . To reduce the effects of clonal differences, we compared the responses of specific clones with or without induction of test protein expression prior to the establishment of silencing. Based on that comparison, we found that the wildtype VP35 and both mutant VP35 proteins permitted significantly more reporter protein expression following DOX induction than was observed in noninduced cells. Previous analysis of VP35 function demonstrated that the K309A and R312A mutant forms could abrogate PKR activity and eIF-2␣ phosphorylation as efficiently as the wild-type protein, resulting in enhanced (nonspecific) protein expression (12, 45) . Thus, the ability of the R312A mutant protein to increase Fluc expression at significantly lower levels than either the wild-type or K309A mutant in our reporter assays suggests that it is the RSS activity of R312A that is compromised in the miR-directed assay. In other words, the enhancement of reporter activity by R312A is likely due to the nonspecific translational effect of VP35 caused by its PKR antagonism, whereas the cumulative effect of VP35 in mammalian systems (by the wild type and the K309A mutant) reflects both specific RSS activity and nonspecific relief of translational inhibition caused by stressinduced kinases. This interpretation would explain the higher levels of reporter expression observed in silenced cells that express VP35 (wild type or K309A) than in cells that were not silenced (miR21 only) or were silenced but expressed an irrelevant gene ( Fig. 1E and 2A) .
Our ability to observe wild-type levels of microRNA-directed silencing suppression by the K309A mutant differs from the results of Haasnoot and coworkers, who concluded that neither K309A nor R312A could suppress silencing by short hairpin transcripts (15) . Since these investigators introduced the VP35-expressing plasmids at the same time as the reporter and silencing constructs, silencing could have been established prior to significant expression of VP35 protein, or expression of VP35 protein could have been significantly less than we obtained in our studies. In our hands, we observed the most potent silencing suppression when VP35 proteins were present prior to the introduction of silencing plasmids, either by transfecting the VP35 expression plasmid a day prior to transfection with silencing mixtures (Fig.  1E) or by expressing VP35 proteins in stable cell lines by the addition of DOX for 24 h prior to the establishment of silencing ( Fig.  2A) . Moreover, our use of inducible cell lines resulted in VP35 protein (wild type or mutant) expression in Ͼ95% of the cells that were transfected with the silencing mixture. Thus, the inability of Haasnoot et al. to observe silencing suppression by K309A (15) may be due to the failure of the mutant to reverse established silencing, failure to express the mutant protein at sufficiently high levels in most cells, and/or failure to overcome what could be more potent silencing than was present in our experiments.
It is important to note that the difference between the microRNA-directed silencing suppression activities of K309A and R312A mutants cannot be explained by differences in protein expression levels (Fig. 2C) or by their abilities to bind small siRNAs, since neither mutant CTD could bind siRNAs (Fig. 3G and H) . Thus, our results suggest that the microRNA-specific silencing suppression activity of VP35 observed in mammalian cells is not dependent on its ability to bind small RNAs. These results are consistent with a recent report that demonstrated the ability of the RISC-associated proteins PACT and TRBP to bind to EBOV VP35 when overexpressed by transfection (11) . These investigators also reported that the VP35 interactions with PACT and TRBP were not dependent upon the presence of siRNA. Thus, it is likely that VP35 can sequester important RISC components, thereby preventing the assembly or activity of silencing complexes.
PACT has also been shown to activate PKR during stress, leading to an inhibition of translation (32) . The fact that VP35 can associate with and presumably block the activity of PACT may explain the translational enhancement caused by VP35 that is independent of silencing suppression (for example, with the R312A mutant [ Fig. 2A]) and that results in greater reporter expression than is observed in nonsilenced cells (Fig. 1E and 2A) . It is noteworthy that both we ( Fig. 2A) and Fabozzi and colleagues (11) have observed that the silencing-independent translational enhancement caused by VP35 is much less than its effect on either microRNA-or siRNA-directed silencing, confirming the utility of the Fluc expression assays to measure microRNA-directed silencing suppression by VP35.
Suppression of RNA silencing in plants. We show for the first time that EBOV VP35 can suppress silencing in plants using two well-characterized plant silencing suppression assays, further confirming that silencing suppression can occur independently of IFN pathway responses. This increases the number of mammalian virus proteins, including influenza virus NS1 and HIV tat protein, that have been shown to have RSS activity in plants (5, 9, 39) . However, the structure of the VP35 CTD differs markedly from that of other viral RSS proteins or of canonical RNA binding proteins (26, (29) (30) (31) . The two silencing suppression assays differ in the mechanisms by which silencing is induced (23) . In addition, the strengths of the silencing signals differ, which most likely accounts for the residual mild green color in the two-component assay with the K309A and R312A single mutants but not with the double mutant (Fig.  4B) . The two-component system relies on the use of GFPtransgenic plants that are "primed" for silencing by expression of a target transgene, and silencing is triggered by overexpression of the same mRNA from an expression plasmid. This silencing signal is likely to be weaker than that generated from the long GFP hairpin transcript that induces silencing in the three-component system (23) . Nevertheless, both the two-and three-component assays rely on amplification of RNA species (transcripts, hairpins, and/or siRNAs) mediated by host RNAdependent RNA polymerase (31) .
In contrast to microRNA-directed silencing in mammalian systems, the RSS activity of VP35 in plants (Fig. 4) appears to be largely dependent upon VP35 dsRNA binding activity. Thus, only wild-type (but not K309A or R312A mutant) VP35 can effectively bind the siRNA effectors (Fig. 3) and inhibit silencing. Nevertheless, the milder two-component silencing system did permit a low level of GFP expression when the single point mutants were introduced, even after 7 days. The low-level activity suggests that some portion of VP35 RSS activity in plants is independent of its ability to bind short dsRNA molecules. However, since VP35 may interact poorly with the heterologous proteins that make up RISCs in plants, VP35's ability to suppress silencing through protein-protein interactions in plants is not as great as in mammalian cells.
Do silencing suppression mechanisms in plants and mammals differ? Since plants have a potent mechanism to amplify siRNAs and silencing in plants is largely dependent on RNA signal amplification or assembly of functional RISCs (31), it is not surprising that plant-silencing suppression by EBOV VP35 and influenza virus NS1 corresponds to the ability to bind dsRNAs (5, 7) . This is also true of p19 and many other plant RSS proteins, although some also interact with silencing pathway proteins (6) . In mammals, although silencing is dependent upon small dsRNAs (microRNAs or siRNAs), there is no RNAdependent RNA polymerase to amplify either these effector molecules or RNA inducers of the pathways. It is interesting that all mammalian virus proteins reported to have RSS activity, including VP35, influenza virus NS1, and vaccinia virus E3L, are also PKR or IFN antagonists (5, 12, 13, 31, 33, 45) . As suggested by Fabozzi and colleagues, the fact that VP35 interacts with PACT and TRBP, both of which are important effectors in PKR and silencing complexes, may explain this concordance (11) . In animals, could protein signaling molecules, such as IFN, have evolved to amplify the ability of the cells to silence gene expression in the absence of RNA amplification? We have found that a mutated VP35 (R312A) that loses its ability to bind to siRNA (Fig. 3H ) but retains PKR antagonism (45) loses most of its ability to counter microRNA-dependent silencing in mammalian cells (Fig. 2) and most of its ability to suppress RNA silencing in plants (Fig. 4) . Given the fact that the RNA binding domains of many proteins are also protein binding domains (44) , it is possible that the R312A mutation impacts both protein and RNA binding activities of VP35. Indeed, the crystal structure of VP35 with dsRNA shows that the residue is important for interaction between the two monomers arranged in an asymmetric dimer, as well as for backbone RNA binding (26, 30) . Since functional silencing complexes in both plant and animal cells require small RNAs as well as proteins that bind to each other and to siRNA or microRNA in the complex, uncovering the precise mechanism(s) of silencing suppression in each system will require the availability of mutants that differentially disrupt RNA binding but not binding to a particular protein target. 0743261 (D.M.B.). N.C.C. was supported by NIAID fellowship F32 AI082884 during part of this work. J.N.J. was supported by fellowships from the OSU Center for RNA Biology and from Pelotonia.
